SlideShare a Scribd company logo
1 of 45
Proliferative lesions of
ENDOMETRIUM
Endometrial polyp, hyperplasia,
endometrial carcinoma, leiomyoma &
leiomyosarcoma.
Dr Mohammad Manzoor Mashwani
All tend to produce abnormal uterine bleeding as their earliest manifestation.
Endometrial Polyps
Uterine polyp’ is clinical term used for a polypoid growth
projecting into the uterine lumen and may be composed of
benign lesions (e.g. endometrial or mucous polyp,
leiomyomatous polyp and placental polyp), or malignant
polypoid tumours (e.g. endometrial carcinoma, choriocarcinoma
and sarcoma). The most common variety, however,
is the one having the structure like that of endometrium and
is termed endometrial or mucus polyp.
Endometrial polyps
- are focal benign overgrowth of endometrium
- most commonly located on the fundus
- may protrude into vagina and may cause bleeding.
Although endometrial polyps may occur at any age, they most
commonly are detected around the time of menopause.
Their clinical significance lies in abnormal uterine bleeding and,
more important, in the risk (however
rare) of giving rise to a cancer.
Endometrial Polyps
These sessile, usually hemispheric lesions range from
0.5 to 3 cm in diameter.
Larger polyps may project from the endometrial
mucosa into the uterine cavity.
Small endometrial polyps generally remain asymptomatic and are detected
incidentally.
The larger ones may ulcerate, degenerate and result in clinical bleeding
Morphology
Grossly, endometrial polyps may be single or multiple, usually sessile
and small (0.5 to 3 cm in diameter) but occasionally they are large
and pedunculated.
Have 2 patterns —localised polypoid tumour, or a diffuse tumour; the latter being more
common. The tumour protrudes into the endometrial cavity as irregular, friable and grey-tan
mass.
Extension of the growth into the myometrium may be identified by the presence of soft, friable
and granular tissue in cut section.
In advanced disease, the involvement may extend beyond the physiologic limits—into the
cervical canal, into the peritoneum, besides lymphatic metastases and haematogenous
metastases to distant sites such as lungs, liver, bones and other organs.
Morphology
On histologic examination, they are composed of endometrium resembling the
basalis, frequently with small muscular arteries.
Some glands have a normal endometrial architecture, but
more often they are cystically dilated.
The stromal cells are monoclonal, often with a rearrangement of
chromosomal region 6p21, and thus constitute the neoplastic
component of the polyp.
Endometrial polyp ( fibrous stroma harboring dilated glands
lined by columnar epithelium
Endometrial hyperplasia
- exaggerated endometrial proliferation due to excess of estrogen
- can be preneoplastic
- hyperplasia is classified based on crowding of glands and presence of atypia into:
1- simple hyperplasia
2- complex hyperplasia
3- atypical hyperplasia
- these changes depend on the level and duration of the estrogen excess
- risk factors: (estrogen excess)
1- failure of ovulation (e.g. around the menopause)
2- prolonged administration of estrogen
3- estrogen-producing ovarian lesions (polycystic ovaries)
4- Ovarian cortical stromal hyperplasia
5- granulosa-theca cell tumors of the ovary
6- obesity ( because adipose tissue processes steroid precursors into estrogens)
Polycystic ovary syndrome (PCOS), also called hyperandrogenic anovulation (HA), or Stein–
Leventhal syndrome, is a set of symptoms due to a hormone imbalance in women.
A) Simple hyperplasia
- crowding of glands without atypia some of them are dilated (cystic hyperplasia)
:Swiss cheese
- only 1% of cases progress to adenocarcinoma
Swiss
cheese
B) Complex hyperplasia
- crowding and branching of glands without cellular atypia
- 3% of cases progress to adenocarcinoma
C) Atypical hyperplasia
- complex hyperplasia with atypia ( hyperchromatic nuclei, mitotic figures )
- commonly progresses to adenocarcinoma
- treated may be with Tamoxifen (antiestrogen) or hysterectomy
When hyperplasia with atypia is discovered, it must be carefully evaluated for the presence of
cancer and must be monitored by serial endometrial biopsies.
In time, the hyperplasia may proliferate autonomously, no longer requiring estrogen, and
eventually may give rise to carcinoma.
In a significant number of cases, the hyperplasia
is associated with inactivating mutations in the
PTEN tumor suppressor gene, an important brake on signaling
through the PI-3-kinase/AKT signaling pathway
Acquisition of PTEN mutations is believed to be one of
several key steps in the transformation of hyperplasias to
endometrial carcinomas, which also often harbor PTEN
mutations.
Phosphatase and tensin
homolog(PTEN) is
a protein that, in humans, is
encoded by the PTEN gene.
Endometrial carcinoma
- endometrial carcinoma is the most frequent cancer of the female genital tract
Epidemiology and Pathogenesis:
- common between the ages of 55 and 65 years
- arises in two clinical settings:
1- in perimenopausal women with estrogen excess (endometrioid carcinoma)
2- in older women with endometrial atrophy (serous carcinoma)
- Pathogenesis: 1) Endometrioid type: 80%
- related to excess of estrogen
- the risk factors:
1- nulliparity
2- early menarche or late menopause
3- obesity (increased synthesis of estrogens )
In the United States and many other Western countries,
endometrial carcinoma is the most frequent cancer occurring in the female genital tract. In Asia
Cervical cancer common.
These tumors are designated
endometrioid because of their histologic
similarity to normal endometrial glands.
UTERINE CANCER
4- Diabetes Hypertension Infertility: women tend to be nulliparous, often with
anovulatory cycles.
5- prolonged estrogen replacement therapy
6- estrogen-secreting ovarian lesions
7- endometrial hyperplasia
- genetic abnormality: 1- mutations in DNA mismatch repair gene
2- mutations in PTEN, a tumor suppressor gene
2) Serous type: 15%
- is a distinct type
- It typically arises in a background of atrophy
- sometimes arises in endometrial polyp
- nearly all cases have mutations in the p53 tumor suppressor gene
Cowden syndrome (also known as "Cowden's disease," and "Multiple hamartoma syndrome"[ is
a rare autosomal dominantinherited disorder characterized by multiple tumor-like growths
called hamartomas and an increased risk of certain forms of cancer (Endometrium, Breast,
Thyroid). It is associated with mutations in PTEN, a tumor suppressor gene
Whereas the decline in the incidence of cervical
cancer in the developed countries is due to aggressive cervical
screening programme leading to early detection and cure of
in situ stage, increased frequency of endometrial carcinoma
in these countries may be due to longevity of women’s life
to develop this cancer of older females.
Morphology:
- Endometrioid carcinomas: - closely resemble normal endometrium
- may be exophytic or infiltrative
- may infiltrate the myometrium and enter vascular
spaces, with metastases to regional lymph nodes
- four stages: stage I: confined to the corpus
stage II: involvement of the cervix
stage III: beyond the uterus but within the
true pelvis
stage IV: distant metastases or involvement
of other viscera
- Serous carcinoma: - forms small tufts and papillae rather than the glands
- has much greater cytologic atypia
- They behave as poorly differentiated cancers and are aggressive
They include a range of histologic types,
including
those showing mucinous, tubal (ciliated), and
squamous
(occasionally adenosquamous) differentiation.
Tumors originate
in the mucosa and may infiltrate the
myometrium and
enter vascular spaces. They may also
metastasize to regional
lymph nodes. Endometrioid carcinomas are
graded I to III,
based on the degree of differentiation.
Endometrial carcinoma. The most common histologic pattern is well-
differentiated adenocarcinoma showing closely packed
(back-to-back) glands with cytologic atypia.
(A, B )Endometrioid carcinoma (C ) Serous carcinoma of the endometrium displaying
formation of papillae and marked cytologic atypia (D )Immunohistochemical stain for
p53 reveals accumulation of mutant p53 in serous carcinoma.
Clinical course:- first clinical indication is marked leukorrhea and irregular bleeding
- With progression, the uterus becomes enlarged and affixed to
surrounding structures.
- metastases to cervix, tubes, ovaries, vagina, broad ligament, regional
LN, lungs, liver
These tumors usually are slow to metastasize, but if left untreated, eventually disseminate to
regional nodes and more distant sites. With therapy, the 5-year survival rate for early-stage
carcinoma is 90%, but survival drops precipitously in higher-stage tumors. The prognosis with
serous carcinomas is strongly dependent on operative staging and cytologic screening of
peritoneal washings; the latter is imperative, because very small or superficial serous tumors
may nonetheless spread by way of the fallopian tube to the peritoneal cavity.
Uterine Fibroids
LEIOMYOMA
Fibromyoma
MYOMA
Leio means smooth
Uterine Fibroids
Leiomyomas or fibromyomas, commonly called fibroids by
the gynaecologists, are the most common uterine tumours
of smooth muscle origin, often admixed with variable amount
of fibrous tissue component.
•Common – 25% of women in a lifetime
•Usually multiple
•Various sizes
•Genetic predisposition
•more common in black races
•More common in the obese
•Less common in smokers
•More common in nulliparas
•Accounts for ~30-75% of hysterectomies
Malignant transformation occurs in less than 0.5% of
leiomyomas.
Because of their firmness, they often are
referred to clinically as fibroids
These fibroids develop in the outer
portion of the uterus and continue to
grow outward
Subserosal uterine
fibroids
The most common type of
fibroid. These develop within the
uterine wall and expand making the
uterus feel larger than normal (which
may cause "bulk symptoms)
Intramural uterine
fibroids
These fibroids develop just under the
lining of the uterine cavity. These are
the fibroids that have the most effect
on heavy menstrual bleeding and the
ones that can cause problems with
infertility and miscarriage
Submucosal uterine
fibroids
Leiomyoma, Uterus (Fibroid)
There are three primary types of uterine fibroids, classified primarily according to
location in the uterus:
Subserosal tumors may extend out on attenuated stalks and even become attached to
surrounding organs, from which they may develop a blood supply (parasitic leiomyomas).
[15%]
[20%]
[60%]
CLASSIFICATION
•Submucous
leiomyoma
•Pedunculated
submucous
•Intramural or
interstitial
•Subserous or
subperitoneal
•Pedunculated
abdominal
•Parasitic
•Intraligmentary
•Cervical
ETIOLOGY
•Unknown
•Each individual myoma is unicellular in origin
•Estogens no evidence that it is a causative factor , it
has been implicated in growth of myomas
•Myomas contain estrogen receptors in higher
concentration than surrounding myometrium
•Myomas may increase in size with estrogen therapy &
in pregnancy & decrease after menopause
•& castration. They are not detectable before puberty
•There may be genetic predisposition
•Other possible factors implicated
•in its etiology are human growth hormone and sterility.
Clinical Details
Leiomyoma, Uterus (Fibroid)
Most women with fibroids are asymptomatic. Only 10-20%
of patients require treatment
Fibroid symptoms are related to the number of tumors, as
well as to their size and location
Bleeding: (Menorrhagia)(Most common)
Pain
Pressure
1
2
3
4
Infertility
Menorrhagia may result in severe anemia and can be life
threatening, although this is rare. Menorrhagia usually results
from the erosion of a submucosal fibroid into the endometrial
cavity. Rarely, dilated veins on the surface of a subserosal,
pedunculated fibroid can cause sudden, massive
intraperitoneal bleeding
Bleeding: (Menorrhagia)(Most common)
Leiomyoma, Uterus (Fibroid)
Leiomyoma, Uterus (Fibroid)
Pain
Women may experience abdominal cramping. Pain usually
is felt during menstruation. Less often, pain occurs
intermenstrually
Pressure
Urinary frequency, urgency, and/or incontinence result from
pressure on the bladder
Constipation, difficult defecation, or rectal pain results
from pressure on the colon
Morphology – Gross- location
Leiomyomas are most frequently located in the uterus
where they may occur within the myometrium
(intramural or interstitial), the
serosa (subserosal), or just underneath the endometrium
(submucosal). Subserosal and submucosal leiomyomas
may develop pedicles and protrude as pedunculated
myomas. Leiomyomas may involve the cervix or broad
ligament.
Morphology - Gross
Grossly, irrespective of their location,
leiomyomas are often multiple,
circumscribed , firm, nodular, grey-white
masses of variable size. On cut section, they
exhibit characteristic whorled pattern
Gross -Characteristics
•Size
–from microscopic to very huge size filling the whole abdominal cavity (up to 40 kg was
recorded).
•Shape
–Spherical, flattened, or pointed according to the type.
•Cut section:
–On cut section,, whorly in appearance, and more pale than the surrounding uterine
muscle.
•Consistency:
–firmer than the surrounding myometrium.
–Soft fibroid occurs in pregnancy, cystic changes, vascular, inflammatory, and malignant
changes.
–Hard fibroid occurs in calcification.
•Capsule:
–Is a pseudo-capsule formed by compressed normal surrounding muscle fibres.
–the blood supply comes through it,
–it is the plain of cleavage during myomectomy
–its presence differentiate the myoma from adenomyosis.
•Blood supply:
–Nourishes the myoma from the periphery,
–The tumor itself is relatively avascular.
Microscopy
Histologically, they are essentially composed of 2
tissue elements—
whorled bundles of smooth muscle cells
admixed with variable amount of connective tissue.
The smooth muscle cells are uniform in size and
shape with abundant cytoplasm and central
oval nuclei
Leiomyoma uterus. Microscopy shows whorls of smooth muscle cells which are spindle-shaped, having
abundant cytoplasm and oval nuclei.
Morphology
Cellular leiomyoma has preponderance of smooth
muscle elements and may superficially resemble leiomyosarcoma
but is distinguished from it by the absence of
mitoses
Morphology – secondary changes
The pathologic appearance may be altered by
secondary changes in the leiomyomas; these include:
•hyaline degeneration,
•cystic degeneration,
•infarction,
•calcification,
•infection and suppuration,
•necrosis,
•Fatty change, and rarely,
•sarcomatous change.
Investigation of Fibroids
•Ultrasound
•MRI better than CT Imaging
•Laparoscopy and Hysteroscopy
Treatment Options for Fibroids
•Hysterectomy
–If the uterus is >10w size
–Or symptoms that are due to the fibroids
–Rapid growth
–Abdominal or vaginal
•Myomectomy
–Best for single fibroid in a young woman
–~50% come to hysterectomy within 5 years?
•Hysteroscopic resection
•Uterine artery embolisation (UAE)
•Medical options
–GnRH analogue
–Mirena
Pregnancy Complications Due to Leiomyoma
•Abortion
•Premature labor
•Disturbances in labor
Postpartum hemorrhage
(questionable
•Ectopic pregnancy
•Premature rupture of
membrane
•Dystocia secondary low
segment myoma
•Increase operative deliveries
•Inversion of uterus
LEIOMYOSARCOMA
Leiomyosarcomas arise de novo from the mesenchymal cells
of the myometrium, not from preexisting leiomyomas. They
are almost always solitary and most often occur in
postmenopausal women, in contradistinction to
leiomyomas,which frequently are multiple and usually arise
premenopausally.
Leiomyosarcoma is an uncommon malignant tumour as
compared to its rather common benign counterpart.
The
incidence of malignancy in pre-existing leiomyoma is less than 0.5% but primary uterine sarcoma is less common than
that which arises in the leiomyoma.
Morphology
Grossly, the tumour may form a diffuse, bulky,
soft and fleshy mass, or a polypoid
mass projecting into lumen.
Morphology
The histologic appearance varies
widely, from tumors that closely resemble leiomyoma to wildly
anaplastic neoplasms. Those well-differentiated tumors
that lie at the interface between leiomyoma and
leiomyosarcoma are sometimes designated smooth muscle
tumors of uncertain malignant potential; in such cases, only
time will tell if the tumor’s behavior is benign or malignant.
The diagnostic features of overt leiomyosarcoma include
tumor necrosis, cytologic atypia, and mitotic activity. Since
increased mitotic activity is sometimes seen in benign smooth
muscle tumors, particularly in young women, an assessment
of all three features is necessary to make a diagnosis of
malignancy.
Histologically, though there are usually some areas
showing whorled arrangement of spindle-shaped smooth
muscle cells having large and hyperchromatic nuclei, the
hallmark of diagnosis and prognosis is the number of
mitoses per high power field (HPF).
The essential diagnostic criteria are: more than 10
mitoses per 10 HPF with or without cellular atypia, or
5-10 mitoses per 10 HPF with cellular atypia. More the
number of mitoses per 10 HPF, worse is the prognosis.
Recurrence & Prognosis
Recurrence after removal is common with these
cancers, and many metastasize, typically to the
lungs, liver, bone & brain yielding a 5-year survival
rate of about 40%.
The outlook with anaplastic tumors is less favorable
than with well-differentiated
tumors.
THANKS

More Related Content

What's hot

Gestational trophoblastic diseases
Gestational trophoblastic diseasesGestational trophoblastic diseases
Gestational trophoblastic diseasesikramdr01
 
Classification of ovarian tumors
Classification of ovarian tumorsClassification of ovarian tumors
Classification of ovarian tumorsDr Anusha Rao P
 
Premalignant and malignant conditions of the cervix
Premalignant and malignant conditions  of the cervix  Premalignant and malignant conditions  of the cervix
Premalignant and malignant conditions of the cervix tariggally
 
Cervical intraepithelial neoplasia
Cervical intraepithelial neoplasiaCervical intraepithelial neoplasia
Cervical intraepithelial neoplasiadrmcbansal
 
ENDOMETRIAL CANCER
ENDOMETRIAL CANCERENDOMETRIAL CANCER
ENDOMETRIAL CANCERAnu Manivannan
 
Benign n pre malignant diseases of cx
Benign n pre malignant diseases of cxBenign n pre malignant diseases of cx
Benign n pre malignant diseases of cxParika Tanwar
 
Uterine sarcoma
Uterine sarcomaUterine sarcoma
Uterine sarcomaHesham Gaber
 
Cervical intra epithelial neoplasia
Cervical intra epithelial neoplasiaCervical intra epithelial neoplasia
Cervical intra epithelial neoplasiaAboubakr Elnashar
 
UTERINE LEIOMYOSARCOMA
UTERINE LEIOMYOSARCOMAUTERINE LEIOMYOSARCOMA
UTERINE LEIOMYOSARCOMApaviarun
 
Pelvic organ prolapse Dr H.K.Cheema
Pelvic organ prolapse  Dr H.K.CheemaPelvic organ prolapse  Dr H.K.Cheema
Pelvic organ prolapse Dr H.K.CheemaDr H.K. Cheema
 
Endometrial Carcinoma
Endometrial CarcinomaEndometrial Carcinoma
Endometrial Carcinomameducationdotnet
 
Ovarian tumors
Ovarian tumorsOvarian tumors
Ovarian tumorsmzdabest
 
Ovarian teratoma
Ovarian teratomaOvarian teratoma
Ovarian teratomaUma Chidiebere
 
Vaginal & cervical carcinoma
Vaginal & cervical carcinomaVaginal & cervical carcinoma
Vaginal & cervical carcinomaSalini Mandal
 
Endometrial hyperplasia
Endometrial hyperplasiaEndometrial hyperplasia
Endometrial hyperplasiaOsama Warda
 
Post menopausal bleeding
Post menopausal bleedingPost menopausal bleeding
Post menopausal bleedingdr.hafsa asim
 
Endometrial hyperplasia.ppt
Endometrial hyperplasia.pptEndometrial hyperplasia.ppt
Endometrial hyperplasia.pptLaxinys
 
Gestational trophoblastic neoplasia
Gestational trophoblastic neoplasiaGestational trophoblastic neoplasia
Gestational trophoblastic neoplasiaNiranjan Chavan
 

What's hot (20)

Gestational trophoblastic diseases
Gestational trophoblastic diseasesGestational trophoblastic diseases
Gestational trophoblastic diseases
 
Cancer of the Vulva
Cancer of the VulvaCancer of the Vulva
Cancer of the Vulva
 
Classification of ovarian tumors
Classification of ovarian tumorsClassification of ovarian tumors
Classification of ovarian tumors
 
Premalignant and malignant conditions of the cervix
Premalignant and malignant conditions  of the cervix  Premalignant and malignant conditions  of the cervix
Premalignant and malignant conditions of the cervix
 
Cervical intraepithelial neoplasia
Cervical intraepithelial neoplasiaCervical intraepithelial neoplasia
Cervical intraepithelial neoplasia
 
ENDOMETRIAL CANCER
ENDOMETRIAL CANCERENDOMETRIAL CANCER
ENDOMETRIAL CANCER
 
Benign n pre malignant diseases of cx
Benign n pre malignant diseases of cxBenign n pre malignant diseases of cx
Benign n pre malignant diseases of cx
 
Uterine sarcoma
Uterine sarcomaUterine sarcoma
Uterine sarcoma
 
Cervical intra epithelial neoplasia
Cervical intra epithelial neoplasiaCervical intra epithelial neoplasia
Cervical intra epithelial neoplasia
 
UTERINE LEIOMYOSARCOMA
UTERINE LEIOMYOSARCOMAUTERINE LEIOMYOSARCOMA
UTERINE LEIOMYOSARCOMA
 
Pelvic organ prolapse Dr H.K.Cheema
Pelvic organ prolapse  Dr H.K.CheemaPelvic organ prolapse  Dr H.K.Cheema
Pelvic organ prolapse Dr H.K.Cheema
 
Endometrial Carcinoma
Endometrial CarcinomaEndometrial Carcinoma
Endometrial Carcinoma
 
Ovarian tumors
Ovarian tumorsOvarian tumors
Ovarian tumors
 
Ovarian teratoma
Ovarian teratomaOvarian teratoma
Ovarian teratoma
 
Vaginal & cervical carcinoma
Vaginal & cervical carcinomaVaginal & cervical carcinoma
Vaginal & cervical carcinoma
 
Endometrial hyperplasia
Endometrial hyperplasiaEndometrial hyperplasia
Endometrial hyperplasia
 
Post menopausal bleeding
Post menopausal bleedingPost menopausal bleeding
Post menopausal bleeding
 
Endometrial hyperplasia.ppt
Endometrial hyperplasia.pptEndometrial hyperplasia.ppt
Endometrial hyperplasia.ppt
 
OVARIAN TUMOURS
OVARIAN TUMOURSOVARIAN TUMOURS
OVARIAN TUMOURS
 
Gestational trophoblastic neoplasia
Gestational trophoblastic neoplasiaGestational trophoblastic neoplasia
Gestational trophoblastic neoplasia
 

Similar to Endometrial polyp, hyperplasia, carcinoma

Female Reproductive System/ Disease PtII
Female Reproductive System/ Disease PtIIFemale Reproductive System/ Disease PtII
Female Reproductive System/ Disease PtIIbimmerque
 
Uterine Corpus Tumours
Uterine Corpus TumoursUterine Corpus Tumours
Uterine Corpus TumoursMujeeb M
 
Ovaries and Ovarian Tumours
Ovaries and Ovarian TumoursOvaries and Ovarian Tumours
Ovaries and Ovarian TumoursMujeeb M
 
1. ca ovary staging etiology pathogenesis.pptx
1. ca ovary staging etiology pathogenesis.pptx1. ca ovary staging etiology pathogenesis.pptx
1. ca ovary staging etiology pathogenesis.pptxVivek Ghosh
 
uterus pathological lesions
uterus pathological lesionsuterus pathological lesions
uterus pathological lesionsimrana tanvir
 
Urology 5th year, 3rd lecture (extended/detailed version) (Dr. Ali Kamal)
Urology 5th year, 3rd lecture (extended/detailed version) (Dr. Ali Kamal)Urology 5th year, 3rd lecture (extended/detailed version) (Dr. Ali Kamal)
Urology 5th year, 3rd lecture (extended/detailed version) (Dr. Ali Kamal)College of Medicine, Sulaymaniyah
 
Ovarian Malignant.pptx
Ovarian Malignant.pptxOvarian Malignant.pptx
Ovarian Malignant.pptxVioletteRemedies
 
Ovarian Malignant.pptx
Ovarian Malignant.pptxOvarian Malignant.pptx
Ovarian Malignant.pptxVioletteRemedies
 
Ca ovary staging(AJCC 8th Edition& FIGO 2014) and classification
Ca ovary staging(AJCC 8th Edition& FIGO 2014) and classificationCa ovary staging(AJCC 8th Edition& FIGO 2014) and classification
Ca ovary staging(AJCC 8th Edition& FIGO 2014) and classificationDr.Bhavin Vadodariya
 
Carcinoma Endometrium
Carcinoma  EndometriumCarcinoma  Endometrium
Carcinoma Endometriumdrmcbansal
 
Benign ovarian masses
Benign ovarian masses Benign ovarian masses
Benign ovarian masses Ayesha Safi
 
Gynecology 5th year, 5th & 6th lectures (Dr. Sallama Kamil)
Gynecology 5th year, 5th & 6th lectures (Dr. Sallama Kamil)Gynecology 5th year, 5th & 6th lectures (Dr. Sallama Kamil)
Gynecology 5th year, 5th & 6th lectures (Dr. Sallama Kamil)College of Medicine, Sulaymaniyah
 
Pathology of Uterine corpus. Dr. Sufia Husain, 2018
Pathology of Uterine corpus. Dr. Sufia Husain, 2018Pathology of Uterine corpus. Dr. Sufia Husain, 2018
Pathology of Uterine corpus. Dr. Sufia Husain, 2018Sufia Husain
 
Carcinoma endometrium Dr. M.C.Bansal
Carcinoma  endometrium  Dr. M.C.BansalCarcinoma  endometrium  Dr. M.C.Bansal
Carcinoma endometrium Dr. M.C.Bansaldrmcbansal
 
Ca ovary staging etiology pathogenesis
Ca ovary staging etiology pathogenesisCa ovary staging etiology pathogenesis
Ca ovary staging etiology pathogenesisNilesh Kucha
 
gynaecology.Ovarian tumours.(dr.salama)
gynaecology.Ovarian tumours.(dr.salama)gynaecology.Ovarian tumours.(dr.salama)
gynaecology.Ovarian tumours.(dr.salama)student
 
Lect 3- overy cancer
Lect 3- overy cancerLect 3- overy cancer
Lect 3- overy cancerMohanad Mohanad
 

Similar to Endometrial polyp, hyperplasia, carcinoma (20)

Female Reproductive System/ Disease PtII
Female Reproductive System/ Disease PtIIFemale Reproductive System/ Disease PtII
Female Reproductive System/ Disease PtII
 
Uterine Corpus Tumours
Uterine Corpus TumoursUterine Corpus Tumours
Uterine Corpus Tumours
 
Ovaries and Ovarian Tumours
Ovaries and Ovarian TumoursOvaries and Ovarian Tumours
Ovaries and Ovarian Tumours
 
1. ca ovary staging etiology pathogenesis.pptx
1. ca ovary staging etiology pathogenesis.pptx1. ca ovary staging etiology pathogenesis.pptx
1. ca ovary staging etiology pathogenesis.pptx
 
uterus pathological lesions
uterus pathological lesionsuterus pathological lesions
uterus pathological lesions
 
Urology 5th year, 3rd lecture (extended/detailed version) (Dr. Ali Kamal)
Urology 5th year, 3rd lecture (extended/detailed version) (Dr. Ali Kamal)Urology 5th year, 3rd lecture (extended/detailed version) (Dr. Ali Kamal)
Urology 5th year, 3rd lecture (extended/detailed version) (Dr. Ali Kamal)
 
Ovarian Malignant.pptx
Ovarian Malignant.pptxOvarian Malignant.pptx
Ovarian Malignant.pptx
 
Ovarian Malignant.pptx
Ovarian Malignant.pptxOvarian Malignant.pptx
Ovarian Malignant.pptx
 
Ca ovary staging(AJCC 8th Edition& FIGO 2014) and classification
Ca ovary staging(AJCC 8th Edition& FIGO 2014) and classificationCa ovary staging(AJCC 8th Edition& FIGO 2014) and classification
Ca ovary staging(AJCC 8th Edition& FIGO 2014) and classification
 
Neoplasia2003
Neoplasia2003Neoplasia2003
Neoplasia2003
 
Carcinoma Endometrium
Carcinoma  EndometriumCarcinoma  Endometrium
Carcinoma Endometrium
 
Benign ovarian masses
Benign ovarian masses Benign ovarian masses
Benign ovarian masses
 
Gynecology 5th year, 5th & 6th lectures (Dr. Sallama Kamil)
Gynecology 5th year, 5th & 6th lectures (Dr. Sallama Kamil)Gynecology 5th year, 5th & 6th lectures (Dr. Sallama Kamil)
Gynecology 5th year, 5th & 6th lectures (Dr. Sallama Kamil)
 
Endometrium part 1 2018
Endometrium part 1 2018Endometrium part 1 2018
Endometrium part 1 2018
 
Pathology of Uterine corpus. Dr. Sufia Husain, 2018
Pathology of Uterine corpus. Dr. Sufia Husain, 2018Pathology of Uterine corpus. Dr. Sufia Husain, 2018
Pathology of Uterine corpus. Dr. Sufia Husain, 2018
 
Carcinoma endometrium Dr. M.C.Bansal
Carcinoma  endometrium  Dr. M.C.BansalCarcinoma  endometrium  Dr. M.C.Bansal
Carcinoma endometrium Dr. M.C.Bansal
 
Ca ovary staging etiology pathogenesis
Ca ovary staging etiology pathogenesisCa ovary staging etiology pathogenesis
Ca ovary staging etiology pathogenesis
 
gynaecology.Ovarian tumours.(dr.salama)
gynaecology.Ovarian tumours.(dr.salama)gynaecology.Ovarian tumours.(dr.salama)
gynaecology.Ovarian tumours.(dr.salama)
 
Lect 3- overy cancer
Lect 3- overy cancerLect 3- overy cancer
Lect 3- overy cancer
 
uterus.ppt
uterus.pptuterus.ppt
uterus.ppt
 

More from Mohammad Manzoor

Chronic cholecystitis practical
Chronic cholecystitis practicalChronic cholecystitis practical
Chronic cholecystitis practicalMohammad Manzoor
 
L cholecystitis students
L cholecystitis studentsL cholecystitis students
L cholecystitis studentsMohammad Manzoor
 
L acute appendicitis
L acute appendicitisL acute appendicitis
L acute appendicitisMohammad Manzoor
 
Granuloma lecture st
Granuloma lecture stGranuloma lecture st
Granuloma lecture stMohammad Manzoor
 
Granulation tissue formation
Granulation tissue formationGranulation tissue formation
Granulation tissue formationMohammad Manzoor
 
Tissue processing by dr manzoor
Tissue processing by dr manzoorTissue processing by dr manzoor
Tissue processing by dr manzoorMohammad Manzoor
 
Liver cirrhosis for students n
Liver cirrhosis for students nLiver cirrhosis for students n
Liver cirrhosis for students nMohammad Manzoor
 
L1 nomenclature of tumors
L1 nomenclature of tumorsL1 nomenclature of tumors
L1 nomenclature of tumorsMohammad Manzoor
 
Characteristics of neoplasms
Characteristics of neoplasmsCharacteristics of neoplasms
Characteristics of neoplasmsMohammad Manzoor
 
L acute appendicitis
L acute appendicitisL acute appendicitis
L acute appendicitisMohammad Manzoor
 
Non neoplastic disorders of endometrium
Non neoplastic disorders of endometriumNon neoplastic disorders of endometrium
Non neoplastic disorders of endometriumMohammad Manzoor
 
Esophageal disorders
Esophageal disordersEsophageal disorders
Esophageal disordersMohammad Manzoor
 
L31 cholecystitis students
L31 cholecystitis studentsL31 cholecystitis students
L31 cholecystitis studentsMohammad Manzoor
 
L31 cholecystitis students
L31 cholecystitis studentsL31 cholecystitis students
L31 cholecystitis studentsMohammad Manzoor
 
L30 gallstones student
L30 gallstones studentL30 gallstones student
L30 gallstones studentMohammad Manzoor
 
L29 hepatocellular carcinoma
L29 hepatocellular carcinomaL29 hepatocellular carcinoma
L29 hepatocellular carcinomaMohammad Manzoor
 

More from Mohammad Manzoor (20)

Chronic cholecystitis practical
Chronic cholecystitis practicalChronic cholecystitis practical
Chronic cholecystitis practical
 
L cholecystitis students
L cholecystitis studentsL cholecystitis students
L cholecystitis students
 
L acute appendicitis
L acute appendicitisL acute appendicitis
L acute appendicitis
 
Granuloma lecture st
Granuloma lecture stGranuloma lecture st
Granuloma lecture st
 
Prostate
ProstateProstate
Prostate
 
Granulation tissue formation
Granulation tissue formationGranulation tissue formation
Granulation tissue formation
 
Fatty liver
Fatty liverFatty liver
Fatty liver
 
Tissue processing by dr manzoor
Tissue processing by dr manzoorTissue processing by dr manzoor
Tissue processing by dr manzoor
 
Liver cirrhosis for students n
Liver cirrhosis for students nLiver cirrhosis for students n
Liver cirrhosis for students n
 
Skin cancer
Skin cancerSkin cancer
Skin cancer
 
Lipoma by manzoor
Lipoma by manzoorLipoma by manzoor
Lipoma by manzoor
 
L1 nomenclature of tumors
L1 nomenclature of tumorsL1 nomenclature of tumors
L1 nomenclature of tumors
 
Characteristics of neoplasms
Characteristics of neoplasmsCharacteristics of neoplasms
Characteristics of neoplasms
 
L acute appendicitis
L acute appendicitisL acute appendicitis
L acute appendicitis
 
Non neoplastic disorders of endometrium
Non neoplastic disorders of endometriumNon neoplastic disorders of endometrium
Non neoplastic disorders of endometrium
 
Esophageal disorders
Esophageal disordersEsophageal disorders
Esophageal disorders
 
L31 cholecystitis students
L31 cholecystitis studentsL31 cholecystitis students
L31 cholecystitis students
 
L31 cholecystitis students
L31 cholecystitis studentsL31 cholecystitis students
L31 cholecystitis students
 
L30 gallstones student
L30 gallstones studentL30 gallstones student
L30 gallstones student
 
L29 hepatocellular carcinoma
L29 hepatocellular carcinomaL29 hepatocellular carcinoma
L29 hepatocellular carcinoma
 

Recently uploaded

Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxDr.Nusrat Tariq
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxbkling
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...saminamagar
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?bkling
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingArunagarwal328757
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...saminamagar
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
PresentaciĂł "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
PresentaciĂł "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...PresentaciĂł "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
PresentaciĂł "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 

Recently uploaded (20)

Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptx
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptx
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, Pricing
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
PresentaciĂł "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
PresentaciĂł "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...PresentaciĂł "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
PresentaciĂł "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 

Endometrial polyp, hyperplasia, carcinoma

  • 1. Proliferative lesions of ENDOMETRIUM Endometrial polyp, hyperplasia, endometrial carcinoma, leiomyoma & leiomyosarcoma. Dr Mohammad Manzoor Mashwani All tend to produce abnormal uterine bleeding as their earliest manifestation.
  • 2. Endometrial Polyps Uterine polyp’ is clinical term used for a polypoid growth projecting into the uterine lumen and may be composed of benign lesions (e.g. endometrial or mucous polyp, leiomyomatous polyp and placental polyp), or malignant polypoid tumours (e.g. endometrial carcinoma, choriocarcinoma and sarcoma). The most common variety, however, is the one having the structure like that of endometrium and is termed endometrial or mucus polyp.
  • 3. Endometrial polyps - are focal benign overgrowth of endometrium - most commonly located on the fundus - may protrude into vagina and may cause bleeding. Although endometrial polyps may occur at any age, they most commonly are detected around the time of menopause. Their clinical significance lies in abnormal uterine bleeding and, more important, in the risk (however rare) of giving rise to a cancer.
  • 4. Endometrial Polyps These sessile, usually hemispheric lesions range from 0.5 to 3 cm in diameter. Larger polyps may project from the endometrial mucosa into the uterine cavity. Small endometrial polyps generally remain asymptomatic and are detected incidentally. The larger ones may ulcerate, degenerate and result in clinical bleeding
  • 5. Morphology Grossly, endometrial polyps may be single or multiple, usually sessile and small (0.5 to 3 cm in diameter) but occasionally they are large and pedunculated. Have 2 patterns —localised polypoid tumour, or a diffuse tumour; the latter being more common. The tumour protrudes into the endometrial cavity as irregular, friable and grey-tan mass. Extension of the growth into the myometrium may be identified by the presence of soft, friable and granular tissue in cut section. In advanced disease, the involvement may extend beyond the physiologic limits—into the cervical canal, into the peritoneum, besides lymphatic metastases and haematogenous metastases to distant sites such as lungs, liver, bones and other organs.
  • 6. Morphology On histologic examination, they are composed of endometrium resembling the basalis, frequently with small muscular arteries. Some glands have a normal endometrial architecture, but more often they are cystically dilated. The stromal cells are monoclonal, often with a rearrangement of chromosomal region 6p21, and thus constitute the neoplastic component of the polyp.
  • 7. Endometrial polyp ( fibrous stroma harboring dilated glands lined by columnar epithelium
  • 8. Endometrial hyperplasia - exaggerated endometrial proliferation due to excess of estrogen - can be preneoplastic - hyperplasia is classified based on crowding of glands and presence of atypia into: 1- simple hyperplasia 2- complex hyperplasia 3- atypical hyperplasia - these changes depend on the level and duration of the estrogen excess - risk factors: (estrogen excess) 1- failure of ovulation (e.g. around the menopause) 2- prolonged administration of estrogen 3- estrogen-producing ovarian lesions (polycystic ovaries) 4- Ovarian cortical stromal hyperplasia 5- granulosa-theca cell tumors of the ovary 6- obesity ( because adipose tissue processes steroid precursors into estrogens) Polycystic ovary syndrome (PCOS), also called hyperandrogenic anovulation (HA), or Stein– Leventhal syndrome, is a set of symptoms due to a hormone imbalance in women.
  • 9. A) Simple hyperplasia - crowding of glands without atypia some of them are dilated (cystic hyperplasia) :Swiss cheese - only 1% of cases progress to adenocarcinoma Swiss cheese
  • 10. B) Complex hyperplasia - crowding and branching of glands without cellular atypia - 3% of cases progress to adenocarcinoma
  • 11. C) Atypical hyperplasia - complex hyperplasia with atypia ( hyperchromatic nuclei, mitotic figures ) - commonly progresses to adenocarcinoma - treated may be with Tamoxifen (antiestrogen) or hysterectomy
  • 12. When hyperplasia with atypia is discovered, it must be carefully evaluated for the presence of cancer and must be monitored by serial endometrial biopsies. In time, the hyperplasia may proliferate autonomously, no longer requiring estrogen, and eventually may give rise to carcinoma. In a significant number of cases, the hyperplasia is associated with inactivating mutations in the PTEN tumor suppressor gene, an important brake on signaling through the PI-3-kinase/AKT signaling pathway Acquisition of PTEN mutations is believed to be one of several key steps in the transformation of hyperplasias to endometrial carcinomas, which also often harbor PTEN mutations. Phosphatase and tensin homolog(PTEN) is a protein that, in humans, is encoded by the PTEN gene.
  • 13. Endometrial carcinoma - endometrial carcinoma is the most frequent cancer of the female genital tract Epidemiology and Pathogenesis: - common between the ages of 55 and 65 years - arises in two clinical settings: 1- in perimenopausal women with estrogen excess (endometrioid carcinoma) 2- in older women with endometrial atrophy (serous carcinoma) - Pathogenesis: 1) Endometrioid type: 80% - related to excess of estrogen - the risk factors: 1- nulliparity 2- early menarche or late menopause 3- obesity (increased synthesis of estrogens ) In the United States and many other Western countries, endometrial carcinoma is the most frequent cancer occurring in the female genital tract. In Asia Cervical cancer common. These tumors are designated endometrioid because of their histologic similarity to normal endometrial glands. UTERINE CANCER
  • 14. 4- Diabetes Hypertension Infertility: women tend to be nulliparous, often with anovulatory cycles. 5- prolonged estrogen replacement therapy 6- estrogen-secreting ovarian lesions 7- endometrial hyperplasia - genetic abnormality: 1- mutations in DNA mismatch repair gene 2- mutations in PTEN, a tumor suppressor gene 2) Serous type: 15% - is a distinct type - It typically arises in a background of atrophy - sometimes arises in endometrial polyp - nearly all cases have mutations in the p53 tumor suppressor gene Cowden syndrome (also known as "Cowden's disease," and "Multiple hamartoma syndrome"[ is a rare autosomal dominantinherited disorder characterized by multiple tumor-like growths called hamartomas and an increased risk of certain forms of cancer (Endometrium, Breast, Thyroid). It is associated with mutations in PTEN, a tumor suppressor gene Whereas the decline in the incidence of cervical cancer in the developed countries is due to aggressive cervical screening programme leading to early detection and cure of in situ stage, increased frequency of endometrial carcinoma in these countries may be due to longevity of women’s life to develop this cancer of older females.
  • 15. Morphology: - Endometrioid carcinomas: - closely resemble normal endometrium - may be exophytic or infiltrative - may infiltrate the myometrium and enter vascular spaces, with metastases to regional lymph nodes - four stages: stage I: confined to the corpus stage II: involvement of the cervix stage III: beyond the uterus but within the true pelvis stage IV: distant metastases or involvement of other viscera - Serous carcinoma: - forms small tufts and papillae rather than the glands - has much greater cytologic atypia - They behave as poorly differentiated cancers and are aggressive They include a range of histologic types, including those showing mucinous, tubal (ciliated), and squamous (occasionally adenosquamous) differentiation. Tumors originate in the mucosa and may infiltrate the myometrium and enter vascular spaces. They may also metastasize to regional lymph nodes. Endometrioid carcinomas are graded I to III, based on the degree of differentiation.
  • 16. Endometrial carcinoma. The most common histologic pattern is well- differentiated adenocarcinoma showing closely packed (back-to-back) glands with cytologic atypia.
  • 17. (A, B )Endometrioid carcinoma (C ) Serous carcinoma of the endometrium displaying formation of papillae and marked cytologic atypia (D )Immunohistochemical stain for p53 reveals accumulation of mutant p53 in serous carcinoma.
  • 18.
  • 19. Clinical course:- first clinical indication is marked leukorrhea and irregular bleeding - With progression, the uterus becomes enlarged and affixed to surrounding structures. - metastases to cervix, tubes, ovaries, vagina, broad ligament, regional LN, lungs, liver These tumors usually are slow to metastasize, but if left untreated, eventually disseminate to regional nodes and more distant sites. With therapy, the 5-year survival rate for early-stage carcinoma is 90%, but survival drops precipitously in higher-stage tumors. The prognosis with serous carcinomas is strongly dependent on operative staging and cytologic screening of peritoneal washings; the latter is imperative, because very small or superficial serous tumors may nonetheless spread by way of the fallopian tube to the peritoneal cavity.
  • 21. Uterine Fibroids Leiomyomas or fibromyomas, commonly called fibroids by the gynaecologists, are the most common uterine tumours of smooth muscle origin, often admixed with variable amount of fibrous tissue component. •Common – 25% of women in a lifetime •Usually multiple •Various sizes •Genetic predisposition •more common in black races •More common in the obese •Less common in smokers •More common in nulliparas •Accounts for ~30-75% of hysterectomies Malignant transformation occurs in less than 0.5% of leiomyomas. Because of their firmness, they often are referred to clinically as fibroids
  • 22. These fibroids develop in the outer portion of the uterus and continue to grow outward Subserosal uterine fibroids The most common type of fibroid. These develop within the uterine wall and expand making the uterus feel larger than normal (which may cause "bulk symptoms) Intramural uterine fibroids These fibroids develop just under the lining of the uterine cavity. These are the fibroids that have the most effect on heavy menstrual bleeding and the ones that can cause problems with infertility and miscarriage Submucosal uterine fibroids Leiomyoma, Uterus (Fibroid) There are three primary types of uterine fibroids, classified primarily according to location in the uterus: Subserosal tumors may extend out on attenuated stalks and even become attached to surrounding organs, from which they may develop a blood supply (parasitic leiomyomas).
  • 25. ETIOLOGY •Unknown •Each individual myoma is unicellular in origin •Estogens no evidence that it is a causative factor , it has been implicated in growth of myomas •Myomas contain estrogen receptors in higher concentration than surrounding myometrium •Myomas may increase in size with estrogen therapy & in pregnancy & decrease after menopause •& castration. They are not detectable before puberty •There may be genetic predisposition •Other possible factors implicated •in its etiology are human growth hormone and sterility.
  • 26. Clinical Details Leiomyoma, Uterus (Fibroid) Most women with fibroids are asymptomatic. Only 10-20% of patients require treatment Fibroid symptoms are related to the number of tumors, as well as to their size and location Bleeding: (Menorrhagia)(Most common) Pain Pressure 1 2 3 4 Infertility
  • 27. Menorrhagia may result in severe anemia and can be life threatening, although this is rare. Menorrhagia usually results from the erosion of a submucosal fibroid into the endometrial cavity. Rarely, dilated veins on the surface of a subserosal, pedunculated fibroid can cause sudden, massive intraperitoneal bleeding Bleeding: (Menorrhagia)(Most common) Leiomyoma, Uterus (Fibroid)
  • 28. Leiomyoma, Uterus (Fibroid) Pain Women may experience abdominal cramping. Pain usually is felt during menstruation. Less often, pain occurs intermenstrually Pressure Urinary frequency, urgency, and/or incontinence result from pressure on the bladder Constipation, difficult defecation, or rectal pain results from pressure on the colon
  • 29. Morphology – Gross- location Leiomyomas are most frequently located in the uterus where they may occur within the myometrium (intramural or interstitial), the serosa (subserosal), or just underneath the endometrium (submucosal). Subserosal and submucosal leiomyomas may develop pedicles and protrude as pedunculated myomas. Leiomyomas may involve the cervix or broad ligament.
  • 30. Morphology - Gross Grossly, irrespective of their location, leiomyomas are often multiple, circumscribed , firm, nodular, grey-white masses of variable size. On cut section, they exhibit characteristic whorled pattern
  • 31. Gross -Characteristics •Size –from microscopic to very huge size filling the whole abdominal cavity (up to 40 kg was recorded). •Shape –Spherical, flattened, or pointed according to the type. •Cut section: –On cut section,, whorly in appearance, and more pale than the surrounding uterine muscle. •Consistency: –firmer than the surrounding myometrium. –Soft fibroid occurs in pregnancy, cystic changes, vascular, inflammatory, and malignant changes. –Hard fibroid occurs in calcification. •Capsule: –Is a pseudo-capsule formed by compressed normal surrounding muscle fibres. –the blood supply comes through it, –it is the plain of cleavage during myomectomy –its presence differentiate the myoma from adenomyosis. •Blood supply: –Nourishes the myoma from the periphery, –The tumor itself is relatively avascular.
  • 32.
  • 33. Microscopy Histologically, they are essentially composed of 2 tissue elements— whorled bundles of smooth muscle cells admixed with variable amount of connective tissue. The smooth muscle cells are uniform in size and shape with abundant cytoplasm and central oval nuclei
  • 34. Leiomyoma uterus. Microscopy shows whorls of smooth muscle cells which are spindle-shaped, having abundant cytoplasm and oval nuclei.
  • 35. Morphology Cellular leiomyoma has preponderance of smooth muscle elements and may superficially resemble leiomyosarcoma but is distinguished from it by the absence of mitoses
  • 36. Morphology – secondary changes The pathologic appearance may be altered by secondary changes in the leiomyomas; these include: •hyaline degeneration, •cystic degeneration, •infarction, •calcification, •infection and suppuration, •necrosis, •Fatty change, and rarely, •sarcomatous change.
  • 37. Investigation of Fibroids •Ultrasound •MRI better than CT Imaging •Laparoscopy and Hysteroscopy
  • 38. Treatment Options for Fibroids •Hysterectomy –If the uterus is >10w size –Or symptoms that are due to the fibroids –Rapid growth –Abdominal or vaginal •Myomectomy –Best for single fibroid in a young woman –~50% come to hysterectomy within 5 years? •Hysteroscopic resection •Uterine artery embolisation (UAE) •Medical options –GnRH analogue –Mirena
  • 39. Pregnancy Complications Due to Leiomyoma •Abortion •Premature labor •Disturbances in labor Postpartum hemorrhage (questionable •Ectopic pregnancy •Premature rupture of membrane •Dystocia secondary low segment myoma •Increase operative deliveries •Inversion of uterus
  • 40. LEIOMYOSARCOMA Leiomyosarcomas arise de novo from the mesenchymal cells of the myometrium, not from preexisting leiomyomas. They are almost always solitary and most often occur in postmenopausal women, in contradistinction to leiomyomas,which frequently are multiple and usually arise premenopausally. Leiomyosarcoma is an uncommon malignant tumour as compared to its rather common benign counterpart. The incidence of malignancy in pre-existing leiomyoma is less than 0.5% but primary uterine sarcoma is less common than that which arises in the leiomyoma.
  • 41. Morphology Grossly, the tumour may form a diffuse, bulky, soft and fleshy mass, or a polypoid mass projecting into lumen.
  • 42. Morphology The histologic appearance varies widely, from tumors that closely resemble leiomyoma to wildly anaplastic neoplasms. Those well-differentiated tumors that lie at the interface between leiomyoma and leiomyosarcoma are sometimes designated smooth muscle tumors of uncertain malignant potential; in such cases, only time will tell if the tumor’s behavior is benign or malignant. The diagnostic features of overt leiomyosarcoma include tumor necrosis, cytologic atypia, and mitotic activity. Since increased mitotic activity is sometimes seen in benign smooth muscle tumors, particularly in young women, an assessment of all three features is necessary to make a diagnosis of malignancy.
  • 43. Histologically, though there are usually some areas showing whorled arrangement of spindle-shaped smooth muscle cells having large and hyperchromatic nuclei, the hallmark of diagnosis and prognosis is the number of mitoses per high power field (HPF). The essential diagnostic criteria are: more than 10 mitoses per 10 HPF with or without cellular atypia, or 5-10 mitoses per 10 HPF with cellular atypia. More the number of mitoses per 10 HPF, worse is the prognosis.
  • 44. Recurrence & Prognosis Recurrence after removal is common with these cancers, and many metastasize, typically to the lungs, liver, bone & brain yielding a 5-year survival rate of about 40%. The outlook with anaplastic tumors is less favorable than with well-differentiated tumors.